Uncategorized

European VC Jeito gets $1.2B to help private biotechs control their ‘destiny’

European VC Jeito gets $1.2B to help private biotechs control their ‘destiny’

Published

on

A dozen or so European drug development startups might soon get a major lift from Jeito Capital.

The Paris-based firm closed its second fund at $1.2 billion, or more than €1 billion, Jeito said Wednesday …​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version